Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Entwine Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
Entwine Bio

Entwine Bio

Pre-Seed

San Francisco-based software company specializing in AI-driven proteome engineering via RNA splicing.

HQ
San Francisco, CA, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Entwine Bio, founded in San Francisco, California, is a pioneering software company focused on AI-driven proteome engineering through RNA splicing control. Their core mission is to revolutionize biological engineering by enabling the precise engineering of any protein in any cell. Entwine Bio's innovative approach leverages advanced AI algorithms to program RNA splicing, opening new avenues in biotechnology and therapeutic development.

Notable figures associated with Entwine Bio include co-founders Mona Khalaj, who serves as CEO and Acting CSO, and Colin McNally. The company also benefits from the expertise of academic cofounders and advisors such as Vijay Ramani from The Gladstone Institutes, Hani Goodarzi from UCSF and the Arc Institute, and Balyn Zaro from UCSF. Entwine Bio's groundbreaking work has positioned it as a significant player in the biotech industry, with the potential to make substantial impacts on medical research and treatment methodologies.

Entwine Bio - Similar Companies

Inceptive logo

Inceptive

inceptive.life

Wayfinder Biosciences logo

Wayfinder Biosciences

wayfinderbio.com

Exai Bio logo

Exai Bio

exai.bio

Profluent Bio logo

Profluent Bio

profluent.bio

InterVenn Biosciences logo

InterVenn Biosciences

intervenn.com

Diffuse Bio logo

Diffuse Bio

diffuse.bio

Amber Bio logo

Amber Bio

amber.bio

20n Bio logo

20n Bio

20n.bio

Airna logo

Airna

airna.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Entelexo Biotherapeutics logo

Entelexo Biotherapeutics

entelexo.com

NExTNet logo

NExTNet

nextnetinc.com

Laronde logo

Laronde

laronde.bio

Vibe Bio logo

Vibe Bio

vibebio.com

Selva logo

Selva

Entwine Bio - Quick Facts

Who are Entwine Bio's competitors?

Companies similar to Entwine Bio include Inceptive, Wayfinder Biosciences, Exai Bio and Profluent Bio.

When was Entwine Bio founded?

Entwine Bio was founded in 2022.

Where is Entwine Bio's headquarters located?

Entwine Bio's headquarters is located in San Francisco, CA, US.

When was Entwine Bio's last funding round?

Entwine Bio's most recent funding round was for $1.4M (USD) in June 2022.

How much has Entwine Bio raised to-date?

As of Jun 1, 2022, Entwine Bio has raised a total of $1.4M (USD).

How many employees does Entwine Bio have?

Entwine Bio has 5 employees as of Feb 4, 2024.

Entwine Bio - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Software
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software